Cochlear Stock

Cochlear Gross Profit

The Gross Profit of Cochlear (COH.AX) as of Aug 16, 2026 is 1.73 B AUD. In the previous year, Gross Profit was 1.67 B AUD — a change of 3.25% (higher).

Gross Profit

1.73 BAUD

YoY

3.25%

Last updated:

Gross Profit of Cochlear is 2026 1.73 B AUD. Gross Profit of Cochlear was 2025 1.67 B AUD. It decreases by 3.25% higher compared to the previous year.

The Cochlear Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

GROSS MARGIN (%)
Date
GROSS MARGIN (%)
Jan 1, 2024
74.86 base
Jan 1, 2025
73.74 base
Jan 1, 2026 (e)
74.00 base
Jan 1, 2027 (e)
71.45 base
Jan 1, 2028 (e)
67.28 base
Jan 1, 2029 (e)
64.14 base
Jan 1, 2030 (e)
68.42 base
Jan 1, 2031 (e)
48.62 base
YEARGROSS MARGIN (%)
2031 est 48.62
2030 est 68.42
2029 est 64.14
2028 est 67.28
2027 est 71.45
2026 est 74.00
2025 73.74
2024 74.86
2023 74.79
2022 75.86
2021 73.38
2020 74.54
2019 75.85
2018 73.72
2017 71.94
2016 71.93
2015 71.35
2014 69.35
2013 72.55
2012 74.53
2011 72.62
2010 73.31
2009 72.12
2008 72.31
2007 71.17
2006 71.04
Access this data via the Eulerpool API

Cochlear Revenue

Cochlear Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
2.24 B AUD
509.60 M AUD
356.80 M AUD
Jan 1, 2025
2.34 B AUD
522.90 M AUD
388.90 M AUD
Jan 1, 2026 (e)
2.33 B AUD
538.74 M AUD
310.29 M AUD
Jan 1, 2027 (e)
2.42 B AUD
557.99 M AUD
345.05 M AUD
Jan 1, 2028 (e)
2.57 B AUD
592.59 M AUD
378.40 M AUD
Jan 1, 2029 (e)
2.69 B AUD
621.55 M AUD
417.52 M AUD
Jan 1, 2030 (e)
2.53 B AUD
582.72 M AUD
433.00 M AUD
Jan 1, 2031 (e)
3.55 B AUD
0.00 AUD
685.12 M AUD

Cochlear Margins

Cochlear stock margins

The Cochlear margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Cochlear. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Cochlear.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
74.86 %
22.79 %
15.96 %
Jan 1, 2025
73.74 %
22.32 %
16.60 %
Jan 1, 2026 (e)
73.74 %
23.07 %
13.29 %
Jan 1, 2027 (e)
73.74 %
23.07 %
14.27 %
Jan 1, 2028 (e)
73.74 %
23.07 %
14.73 %
Jan 1, 2029 (e)
73.74 %
23.07 %
15.50 %
Jan 1, 2030 (e)
73.74 %
23.07 %
17.15 %
Jan 1, 2031 (e)
73.74 %
0.00 %
19.28 %

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Gross Profit of Cochlear is 1.73 B AUD in 2026.

Gross Profit of Cochlear changed from 1.67 B AUD to 1.73 B AUD, representing a 3.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit Cochlear since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's Cochlear historically and in real time.

Access this data via the Eulerpool API

Income Statement — Cochlear

All Key Metrics — Cochlear